Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Why is the $1,000 pill cheaper in the UK?

Will the pricing of hepatitis C treatment Sovaldi cause a crisis in American health care, and why is the price lower in the United Kingdom?

Published
10 June 2014
From
Columbia Journalism Review
Project Inform disappointed with direction of California hepatitis C testing bill

During this current legislative season, Project Inform sponsored California Senate Bill (SB) 1303, authored by Senator Norma Torres — a bill that would require healthcare practitioners in all primary care settings, except hospitals and emergency rooms, to make a one-time offer of a hepatitis C test to patients born between 1945 through 1965 (“Baby Boomers”) and other patients with identified risk factors for hepatitis C. The bill was modeled after legislation passed in New York State, based on hepatitis C testing recommendations by the Centers for Disease Control & Prevention (CDC) and the United States Preventive Services Task Force.

Published
10 June 2014
From
Project Inform
England: New study reveals the costs of low uptake of hepatitis C treatment

While there would be a financial cost to rapidly increasing treatment rates, the increase is not as great as you might think because the costs of managing undiagnosed and untreated hepatitis C are so high. Currently, we are paying a very high price in terms of lives lost and burden placed on future health care resources.

Published
10 June 2014
From
Public Health England (press release)
Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C

Perlmutter says that he believes Merck already had the best of two of the three drugs in the needed triple-drug combo: an NS5a inhibitor and a protease inhibitor. He expect that it may be possible to plan a combination trial of Merck’s drugs and Idenix’s lead nuke even before the deal closes.

Published
09 June 2014
From
Forbes
Medicare Will Cover Hepatitis C Screening in Primary Care Settings

Medicare will cover HCV screening for all adults at high risk and one-time screening for all adults born between 1945 and 1965.

Published
09 June 2014
From
aids.gov
Hepatitis Warrior Hiking in China Shows Glaxo Hurdles

Lei Chuang trekked almost 1,000 miles over 80 days from Shanghai to Beijing last summer, along riverbanks and highways, to deliver a petition beseeching China’s leaders to cut the prices of hepatitis B drugs. “If drug companies can afford such huge sums for bribing doctors and hospitals, then they should still be profitable if prices are lowered by 50 percent,” said Guangzhou-based Lei, nicknamed the “Hepatitis B Warrior” by Chinese media. “They could use that money to benefit patients instead.”

Published
30 May 2014
From
Bloomberg
No critical interactions between ledipasvirsofosbuvir and certain key antiretrovirals

Ledipasvir/sofosbuvir, a fixed-dose coformulation of two direct-acting antivirals (DAAs) for HCV infection, did not have a clinically significant impact on five frequently used antiretrovirals--raltegravir, efavirenz, rilpivirine, and tenofovir/emtricitabine (TDF/FTC)--according to results of three studies in healthy volunteers.

Published
29 May 2014
From
NATAP
WHA Adopts Resolution On Hepatitis; Member States Concerned Over High Prices

The resolution urges member states “to develop multisectoral national strategies for preventing, diagnosing, and treating viral hepatitis.” The resolution also asks states to consider using the flexibilities endorsed in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to promote access to specific pharmaceutical products.

Published
23 May 2014
From
Intellectual Property Watch
Today new hepatitis resolution is passed at world health assembly; challenges World Health Organization and member states to act

Today, four years after introducing its first viral hepatitis resolution, the World Health Assembly (WHA)—the decision-making body of the World Health Organization (WHO)—passed the Hepatitis Resolution, which commits the WHO and United Nations (UN) member states to urgent action to address the global hepatitis pandemic, including that of hepatitis C virus (HCV).

Published
23 May 2014
From
Treatment Action Group
Defuse Hepatitis C, the Viral Time Bomb: Test and Treat Hepatitis C

In 2010, the 63rd World Health assembly (WHA) adopted the first resolution on viral hepatitis; a new resolution will be presented at this assembly. We, people living with HCV, HIV/AIDS, people who use drugs, and our advocates, urge United Nations (UN) Member States to act with urgency to end the hepatitis C epidemic; it is possible!

Published
21 May 2014
From
Treatment Action Group

Filter by country